Sorin Group S.p.A. Announces FDA Approval Of World’s Smallest Implantable Cardioverter Defibrillator

BOSTON--(BUSINESS WIRE)--May 16, 2006--ELA Medical, part of Sorin Group (MIL:SRN), announced today at the Heart Rhythm Society’s 27th Annual Scientific Sessions that it received approval from the U.S. Food and Drug Administration (FDA) to market OVATIO(TM), a new family of a dual and single chamber cardioverter defibrillators (ICDs).

MORE ON THIS TOPIC